BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2493220)

  • 1. [Treatment of malignant pleural effusion].
    Takada M; Fukuoka M
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):165-72. PubMed ID: 2493220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
    Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of breast cancer with pleural metastasis responding to administration of intrapleural adriamycin and systemic chemotherapy with FEMP].
    Ogasahara K; Takeda R; Nishizawa F; Yoshimura T; Denno R; Adachi Y; Takahashi J; Kohno Y; Bada K; Ohbayashi M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3140-2. PubMed ID: 3118815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion].
    Suzuki H
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1922-31. PubMed ID: 2608022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intrapleural administration of recombinant interleukin-2 in a patient with pleural effusion due to non-Hodgkin's lymphoma].
    Kojiro N; Ishihara H; Ito M; Nishiki M; Yamashita K; Onoshi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Aug; 27(8):954-9. PubMed ID: 2615111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of recurrent malignant pleural effusion.
    Austin EH; Flye MW
    Ann Thorac Surg; 1979 Aug; 28(2):190-203. PubMed ID: 383031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of intrapleural treatment with aclacinomycin combined with closed tube thoracostomy for malignant pleural effusion].
    Fujii M; Okabe K; Toki H; Fujita Y; Ishimitsu T
    Gan No Rinsho; 1984 Jul; 30(8):895-8. PubMed ID: 6471394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The technique of pleurodesis.
    Elpern EH; Krueger J; Kimsey J; Silver M
    J Crit Illn; 1994 Dec; 9(12):1105-10. PubMed ID: 10150700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to the management of pleural effusion in malignancy.
    Sarma PR; Moore MR
    South Med J; 1978 Feb; 71(2):133-6. PubMed ID: 622621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural effusion treated by tetracycline sclerotherapy. A comparison of single vs repeated instillation.
    Landvater L; Hix WR; Mills M; Siegel RS; Aaron BL
    Chest; 1988 Jun; 93(6):1196-8. PubMed ID: 3371098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in pleurodesis.
    Rodriguez-Panadero F
    Curr Opin Pulm Med; 1997 Jul; 3(4):319-25. PubMed ID: 9262121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of malignant pleural effusion.
    Taubert J
    Nurs Clin North Am; 2001 Dec; 36(4):665-83, vi. PubMed ID: 11726346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Locoregional therapy in patients with malignant pleural effusion--two different types of "BAC therapy"].
    Sugitachi A; Kawahara T; Kido T; Shindoh T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1640-3. PubMed ID: 1530324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of intrapleural administration of pirarubicin (THP-ADM) in the treatment of malignant pleural effusion secondary to lung cancer].
    Makimoto T; Hoshino H; Tsuchiya S; Nakano H; Watanabe S; Naruse I; Fueki N; Ezawa K; Takise A; Saitoh R
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1542-7. PubMed ID: 8121090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant pleural and pericardial effusions.
    Med Lett Drugs Ther; 1981 Jun; 23(13):59-60. PubMed ID: 7242458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intrapleural instillation of recombinant IL-2 in a patient with pleuritis carcinomatosa].
    Kimura H; Yamaguchi Y; Iwai N; Kashiwaya A; Yamakawa H; Baba M; Fujisawa T
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1580-4. PubMed ID: 3263452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Mao G; Gao Z; Wang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):83-4, 127. PubMed ID: 7553956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy.
    Agarwal R; Aggarwal AN; Gupta D
    Respirology; 2006 Jan; 11(1):105-8. PubMed ID: 16423210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.